Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2022 Earnings Call Transcript

Dr. Lishan Aklog: Yeah. So that’s a great question. I don’t have a hard number for you, but we are — it is certainly increasing, now that we’ve plateaued the number, probably, about six months to nine months is, I would say, would be the median. So we have a good median. The median rep has now had a decent time in the field. And as I mentioned on our previous calls, by plateauing our team, it’s freed up the sales leadership to be more active in the field and more active in strategic accounts. We closed a large strategic account a couple of weeks ago that will — and just more time with them, because they’re not spending all the time interviewing and recruiting. So that six-month to nine-month median number will obviously go up as the year progresses and we found that just more time in the field and more experience interacting with physicians and engaging with accounts and trying to make them stickier.

Obviously, an increasing experience will help and that number will go up steadily over the year.

Edward Woo: Great. Well, thank you for answering my questions and I wish you guys good luck. Thank you.

Dr. Lishan Aklog: Thank you. Thanks a lot, Ed.

Operator: And we have no further questions in queue. I’ll turn the call back over to our host.

Dr. Lishan Aklog: Great. So, hey, thank you everybody for taking the time and for spending the morning with us on our update call. We appreciate everybody’s effort and everybody’s support. Feel free to contact us with any further questions, you can get information on our website, luciddx.com or by contacting Mike Parks at mp@lucid — @pavmed.com for any further questions. So thank you very much.

Operator: This concludes today’s conference call. Thank you for attending and have a pleasant day.